Forget Wall Street Analysts: History Says SpaceX Will Reach This Price Target Within the Next Year

The article argues SpaceX's newly public shares could face a roughly 55% peak-to-trough first-year drawdown, implying a possible decline to about $101.53 from a recent high of $225.64. It highlights several bearish factors: a near-131x price-to-sales ratio, staggered insider unlocks, and likely dilution from debt/equity issuance to fund AI data centers and M&A. While initial index-fund buying may support the stock, the overall message is that history and valuation both point to substantial downside risk.

Analysis

The setup is less about whether the stock is “good” and more about whether marginal buyers are forced to own it. That matters because index inclusion plus tiny float can create a short-lived mechanical bid that compresses volatility and makes the first leg higher look fundamental even when it is mostly flow-driven. Once that demand is satisfied, the stock’s path should be governed by unlock cadence and dilution expectations, which is a very different regime than the initial print.

The second-order effect is that this can become a pressure valve for every adjacent high-multiple AI/space name. If the market decides SpaceX can’t sustain a triple-digit sales multiple, it raises the bar for premium valuations across the growth complex and invites rotation into cheaper AI beneficiaries with clearer cash-flow conversion. The most exposed holders are momentum/retail-centric accounts that are buying narrative rather than economics; they are the natural bid on the way up and the most likely source of forced selling on the way down.

The biggest risk to the bearish setup is timing: early index demand can overwhelm valuation gravity for weeks, not days. But the asymmetry still favors fading strength after the first unlock window because every incremental capital raise or share issuance lowers the odds that the market treats the initial float as scarce. In other words, the first drawdown may not be a straight line, but the long-duration path is likely dictated by supply, not story.

The contrarian view is that history may understate the endurance of the bid if passive flows are larger and retail ownership is stickier than prior hot IPO cohorts. If the company uses the listing to fund rapid AI infrastructure buildout and can show even one credible monetization proof point, the market may temporarily tolerate valuation that looks impossible on today’s numbers. That argues for respecting the squeeze risk before the unlock overhang becomes visible.

Key Decisions for Investors

• Fade post-IPO strength after the first index-inclusion window: initiate a starter short only on failed retest of the debut range, with a 3-6 month horizon and a target equal to the first major unlock discount; size small because borrow/squeeze risk is likely elevated.
• Buy downside convexity rather than outright shorting: prefer put spreads 90-180 days out to capture the unlock/dilution overhang while limiting pain if passive demand keeps price elevated into the first few weeks.
• Relative-value pair: long META or NVDA vs short the new listing if it trades at a materially higher sales multiple than the large-cap AI leaders; this isolates valuation compression risk while reducing broad AI beta.
• Use any early squeeze to trim exposure to TSLA if retail enthusiasm spills over into Musk-beta trades; the setup can temporarily support the complex, but it also raises the risk of a crowded factor unwind once the IPO loses novelty.
• Avoid chasing the debut momentum in size; wait for the first post-lockup supply event before adding exposure, since the risk/reward improves materially once float expansion becomes visible.